INT291909

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.03
First Reported 2010
Last Reported 2010
Negated 0
Speculated 0
Reported most in Body
Documents 2
Total Number 2
Disease Relevance 0.08
Pain Relevance 0.09

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

nucleus (BRD2)
BRD2 (Homo sapiens)
Pain Link Frequency Relevance Heat
agonist 11 90.08 High High
antagonist 4 88.92 High High
Potency 6 5.00 Very Low Very Low Very Low
Paracetamol 5 5.00 Very Low Very Low Very Low
Pain 3 5.00 Very Low Very Low Very Low
abdominal pain 2 5.00 Very Low Very Low Very Low
Bioavailability 2 5.00 Very Low Very Low Very Low
headache 2 5.00 Very Low Very Low Very Low
Analgesic 1 5.00 Very Low Very Low Very Low
alcohol 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Reprotox - General 1 6 75.56 Quite High
Ovarian Hyperstimulation Syndrome 11 5.00 Very Low Very Low Very Low
Nicotine Addiction 11 5.00 Very Low Very Low Very Low
Cancer 9 5.00 Very Low Very Low Very Low
Polycystic Ovary Syndrome 9 5.00 Very Low Very Low Very Low
Reprotox - General 2 8 5.00 Very Low Very Low Very Low
Bladder Cancer 8 5.00 Very Low Very Low Very Low
Anovulation 7 5.00 Very Low Very Low Very Low
Reprotox - General 3 5 5.00 Very Low Very Low Very Low
Toxicity 3 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Decreased binding under the conditions of the experiment is uninformative with respect to role of an N-hydroxylamine in DNA adduct formation because the non-oxidized amine is frequently a substrate for NAT.
NAT Binding (binding) of
1) Confidence 0.03 Published 2010 Journal Carcinogenesis Section Body Doc Link PMC2802674 Disease Relevance 0 Pain Relevance 0
They performed a subgroup analysis to compare HP HMG with rFSH and showed a similar outcomes in the HP-HMG group in terms of live birth rate (OR 1.21, 95% CI 1.02 to 1.44) and clinical pregnancy rate (OR 1.26, 95% CI 1.04 to 1.53).77 Two recent RCTs, one using a long downregulation protocol along with a GnRH agonist and the other a GnRH antagonist, failed to demonstrate any significant difference in pregnancy rates between HPFSH and rFSH.98,99
rFSH Binding (compare) of associated with antagonist and agonist
2) Confidence 0.02 Published 2010 Journal Biologics : Targets & Therapy Section Body Doc Link PMC2819896 Disease Relevance 0.08 Pain Relevance 0.09

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox